FNY Investment Advisers’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,730
Closed -$13K 968
2025
Q3
$13K Buy
+2,730
New +$12.1K ﹤0.01% 750
2021
Q1
Sell
-700
Closed -$7K 793
2020
Q4
$7K Sell
700
-4,469
-86% -$45.6K ﹤0.01% 611
2020
Q3
$51K Buy
+5,169
New +$52.2K 0.02% 248

Other funds holding SRTA

FNY Investment Advisers's SRTA Position: Q4 2025 in Review

FNY Investment Advisers sold out of Strata Critical Medical Inc (SRTA) in Q4 2025, closing a stake of 2,730 shares — an estimated $13K sold.

FNY Investment Advisers first reported a position in SRTA in Q3 2020 and held it in 3 quarters. The position peaked at $51K in Q3 2020. 125 funds tracked by Wall St. Rank hold SRTA as of Q4 2025.

  • FNY Investment Advisers reported no remaining Strata Critical Medical Inc position as of Q4 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 2,730 Strata Critical Medical Inc shares in Q4 2025, an estimated $13K.
  • FNY Investment Advisers first reported a position in Strata Critical Medical Inc in Q3 2020 and held it in 3 quarters.
  • FNY Investment Advisers's Strata Critical Medical Inc position peaked at $51K in Q3 2020.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.